These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15863339)

  • 1. Identification of chemokine receptor CCR4 antagonist.
    Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
    Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of 2-aminothiazole derivatives as CCR4 antagonists.
    Wang X; Xu F; Xu Q; Mahmud H; Houze J; Zhu L; Akerman M; Tonn G; Tang L; McMaster BE; Dairaghi DJ; Schall TJ; Collins TL; Medina JC
    Bioorg Med Chem Lett; 2006 May; 16(10):2800-3. PubMed ID: 16497499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
    Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
    Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
    J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2008 Jul; 16(14):7021-32. PubMed ID: 18539035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists.
    Storelli S; Verdijk P; Verzijl D; Timmerman H; van de Stolpe AC; Tensen CP; Smit MJ; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2910-3. PubMed ID: 15911279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of CCR4 as immunomodulatory agents.
    Purandare AV; Somerville JE
    Curr Top Med Chem; 2006; 6(13):1335-44. PubMed ID: 16918452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
    Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
    Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
    Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.